home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  Maintaining Financial Stability and Reducing Cash Burn in the Biotech Sector: Financing Strategies to Foster Growth and Survive in a Challenging Market.  
  October 03, 2002

Biotechnology

 
     
  Marcus Evans, Central London
2003-2-27


Among the issues to be discussed will be:
Market Conditions
Strategies to extend your cash life
Sources of funding
Surviving a downturn: SCENARIO CASE STUDIES
Transparency and its effect on market confidence

 
 
Organized by: Marcus Evans
Invited Speakers: Glen Sato, Chief Financial Officer: EXELIXIS
Stephan Wehselau, Chief Financial Officer: XANTOS BIOMEDICINE AG
Christine Soden, Chief Financial Officer: OXAGEN
Spiro Rombotis, Chief Executive Officer: CYCLACEL LIMITED
Maikel Raghoebar, Chief Development Officer: SEMAIA PHARMACEUTICALS
Dr. Jane Fisken, Managing Director, Head of Global Life Sciences: DRESDNER KLEINWORT CAPITAL
Susan Lowther, Chief Financial Officer: RIBOTARGETS
Barry Riley, Chief Financial Officer: PROTHERICS
Jonathan Pockson, Chief Financial Officer: MICROSCIENCE
Leonard Brooks, Group Head, Private Equity Placement Group: UBS WARBURG
Andrew Skinner, Relationship Director , Technology, Media & Telecoms: BARCLAYS CORPORATE BANKING
Martin Wales, Director, European Biotech: UBS WARBURG
Michael Kilpatrick, Chairman: CAMBRIDGE BIOTECHNOLOGY LTD
 
Deadline for Abstracts: 2003-1-10
 
Registration:
For Full programme
Contact: Jacquie Muhati
Senior Marketing Manager
Tel: +44 020 7647 2304
jacquelynem@marcusevansuk.com
E-mail: jacquelynem@marcusevansuk.com
 
  Posted by:   Jacquie Muhati  
Host: 194.74.216.2
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.